Arsenal's Value Demonstration Acquires Zipher Medical Affairs

Velocity Clinical Research Acquires MedPharmics

September 7, 2022

Healthcare Services

Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.

Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment

May 9, 2022

Healthcare Services

Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.

Arsenal's Value Demonstration Business Acquires Cyan Health

December 8, 2021

Healthcare Services

Arsenal Capital Partners' Value Demonstration business has acquired Cyan Health, a Montclair, New Jersey–based payer marketing and market-access agency. The add-on strengthens Arsenal's Value Demonstration platform capabilities in market access, payer communications, and value demonstration to support life sciences clients and accelerate patient access to new therapies.

Value Demonstration (Arsenal) Acquires Guidemark Health

November 2, 2021

Healthcare Services

Arsenal Capital Partners, through its Value Demonstration healthcare platform, has acquired Guidemark Health, a U.S.-based healthcare marketing communications, training, and medical education agency. The acquisition is the third add-on to Arsenal’s Value Demonstration organization and is intended to deepen the platform’s customer engagement, medical communications, and oncology/rare disease capabilities.

Arsenal Capital Partners Acquires BresMed Health Solutions

February 26, 2020

Healthcare Services

Arsenal Capital Partners acquired BresMed Health Solutions as the first investment to form a new value demonstration platform focused on market access, health economics, outcomes research, patient preference and real-world evidence. BresMed — a global health economics and outcomes research consultancy with more than 150 staff across the U.K., Ireland, the Netherlands, the U.S. and India — will continue to be led by founder Nic Brereton and will join Arsenal’s new platform led operationally by Jon Williams.

Arsenal Capital Partners Acquires Caprion Biosciences from GHO Capital

July 31, 2019

Healthcare Services

Arsenal Capital Partners has acquired Caprion Biosciences from GHO Capital Partners LLP. Caprion is a specialist laboratory services provider focused on immune monitoring (flow cytometry) and quantitative proteomics for pharmaceutical and biotech R&D, with facilities across North America, Europe and Australia.